Senores Pharmaceuticals Limited (NSE:SENORES)

Revenue by Product

Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Regulated Markets	1.45B	Log In	Log In
Regulated Markets Growth	599.86%	Log In	Log In
Emerging Markets	442.02M	Log In	Log In
Application Programming Interface	139.02M	Log In	Log In
Application Programming Interface Growth	602.83%	Log In	Log In
Critical Care Injectables	57.10M	Log In	Log In
Critical Care Injectables Growth	234.90%	Log In	Log In
Other	55.58M	Log In	Log In
Other Growth	-49.07%	Log In	Log In

Revenue by Geography

Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
International	1.67B	Log In	Log In
International Growth	460.20%	Log In	Log In
India	474.29M	Log In	Log In
India Growth	760.94%	Log In	Log In